684221-26-9 Usage
Uses
Used in Pharmaceutical Industry:
Cyclopentaneethanamine hydrochloride is used as a pharmaceutical intermediate for the synthesis of various pharmaceuticals, such as tametraline and amitriptyline. It plays a crucial role in the development of these medications, contributing to their therapeutic effects.
Used in Dye Production:
Cyclopentaneethanamine hydrochloride is used as a precursor in the production of dyes. Its chemical properties make it suitable for use in the synthesis of various types of dyes, contributing to their color and stability.
Used in Corrosion Inhibition:
Cyclopentaneethanamine hydrochloride is also used as a precursor in the production of corrosion inhibitors. Its properties help in the development of effective corrosion inhibitors that protect materials from degradation and extend their service life.
It is important to handle Cyclopentaneethanamine hydrochloride with care, as it can cause irritation to the skin, eyes, and respiratory system. Proper safety measures should be taken during its use to minimize potential health risks.
Check Digit Verification of cas no
The CAS Registry Mumber 684221-26-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,8,4,2,2 and 1 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 684221-26:
(8*6)+(7*8)+(6*4)+(5*2)+(4*2)+(3*1)+(2*2)+(1*6)=159
159 % 10 = 9
So 684221-26-9 is a valid CAS Registry Number.
684221-26-9Relevant academic research and scientific papers
IMIDAZOLYL PYRIMIDINE DERIVATIVES USEFUL AS IL-8 RECEPTOR MODULATORS
-
Page 17, (2010/02/07)
The invention relates to compounds of the formula I, wherein R1, R2, R3 and R4 are each independently selected from H, (1-4C)alkyl, (1-4C)alkoxy, trifluoromethyl, trifluoromethoxy, halogen, amino, sulfonamide, cyano, OH and nitro; R5 is H or (1-6C)alkyl;
Pyrimidine derivatives as IL-8 receptor antagonists
-
Page 28, (2010/02/06)
Compounds containing the pyrimidine nucleus and their use to treat diseases and conditions related to inappropriate Interleukin-8 receptor activity are disclosed. The compounds are of the formula I In these compounds, Q is preferably unsubstituted and substituted heterocyclyl; U is usually hydrogen or fluorine; and V is preferably hydrogen, halogen, alkyl, —O—alkyl or —S-alkyl. A representative example is:
